1582753-01-2

Upstream product

• 905589-27-7 (3S)-4-(tert-butyldiphenylsilyl)oxy-3-(triethylsilyl)oxy-butyraldehyde 
• 1582752-84-8 (R)-3-methylcyclohex-2-en-1-yl (S)-6-(tert-butyldiphenylsilyl)oxy-2-diazo-3-oxo-5-(triethylsilyl)oxyhexanoate 
• 1582752-87-1 (R)-3-methylcyclohex-2-en-1-yl (S)-6-(tert-butyldiphenylsilyl)oxy-2-diazo-5-hydroxy-3-oxohexanoate 
• 1582752-89-3 C₂₉H₃₆O₅Si 
• 1582752-91-7 (R)-3-methylcyclohex-2-en-1-yl (S)-5-[(tert-butyldiphenylsilyl)oxymethyl]-4,5-dihydro-3-methylfuran-2-carboxylate 
• 1582752-93-9 C₃₀H₃₈O₄Si 
• 1582752-95-1 methyl [2S,2(1S),5S]-5-[(tert-butyldiphenylsilyl)oxymethyl]-2-(1-methylcyclohex-2-en-1-yl)-3-methylenetetrahydrofuran-2-carboxylate 
• 1582752-99-5 [2S,2(1S),5S]-[5-(tert-butyldiphenylsilyloxy)methyl-2-(1-methylcyclohex-2-en-1-yl)-3-methylenetetrahydrofuran-2-yl]methanol 

Downstream Products

• 1582753-36-3 (1S,3S,5R,3a'R,7a'S)-3-[(tert-butyldiphenylsilyl)oxymethyl]-5,3a',7a'-trimethyl-2-oxaspiro[cyclopentane-1,1'-hexahydroindan]-4'-one 
• 1582753-09-0 [2S,2(1S),5S]-5-[(tert-butyldiphenylsilyl)oxymethyl]-2-(1-methylcyclohex-2-en-1-yl)-3-methylene-2-(2-nitroethyl)tetrahydrofuran 
• 1582753-05-6 C₃₃H₄₃NO₆Si 

Relevant academic research and scientific papers

Stereoselective synthesis of the CDE ring system of antitumor saponin scillascilloside E-1

A stereoselective synthesis of the CDE ring portion of the antitumor saponin scillascilloside E-1 has been achieved, utilizing an Ireland-Claisen rearrangement to construct the contiguous tetrasubstituted stereocenters at C13 and C17 simultaneously and intramolecular nitrile oxide cycloaddition to form the five-membered ring as key steps.